Identifying the major targets of protective antibodies against malaria

The development of a malaria vaccine would be of great value in Australia’s region where malaria is a leading cause of death and illness and impairs economic development. The project will advance current knowledge of how the immune system fights infections and will contribute to building Australia’s strength in infectious diseases research and developing strategies to combat important infections. The project will help build and maintain expertise in developing vaccines in Australia and the approaches used and knowledge gained will be applicable to understanding and combating other important infections.

Project details

Immunology
Product Development
Vaccines

Jan 2010 — Dec 2013

$724,922

Australia